Role of kallikrein enzymes in the central nervous system

Clinica Chimica Acta

Volumn 329, Issue 1-2, 2003, Pages 1-8

  Yousef, George M ^a,b   Kishi, Tadaaki ^a,b   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; Kallikreins; Neuropsin, central nervous system; Serine proteases

Indexed keywords

KALLIKREIN; NEUROPSIN; SERINE PROTEINASE;

ALZHEIMER DISEASE; BRAIN DEVELOPMENT; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CHROMOSOME 19Q; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE STRUCTURE; GENETIC ANALYSIS; HUMAN; MULTIGENE FAMILY; NONHUMAN; PATHOGENESIS; PLASTICITY; PRIORITY JOURNAL; REVIEW; STRESS;

EID: 0037362720     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00004-4     Document Type: Review

References (75)

1. Clements J. The molecular biology of the kallikreins and their roles in inflammation. Farmer S. The kinin system. 1997;71-97 Academic Press, New York.
2. Yousef G.M., Diamandis E.P. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22:2001;184-204.
3. Yousef G.M., Diamandis E.P. Human kallikreins: common structural features, sequence analysis and evolution. Curr. Genomics. 2003;. [in press].
4. Diamandis E.P., Yousef G.M. Human tissue kallikreins: a family of new cancer biomarkers. Clin. Chem. 48:2002;1198-1205.
5. Yousef G.M., Diamandis E.P. The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation [In Process Citation]. J. Biol. Chem. 274:1999;37511-37516.
6. Yousef G.M., Obiezu C.V., Luo L.Y., Black M.H., Diamandis E.P. Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated. Cancer Res. 59:1999;4252-4256.
7. Yousef G.M., Luo L.Y., Diamandis E.P. Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4. Anticancer Res. 19:1999;2843-2852.
8. Yousef G.M., Scorilas A., Jung K., Ashworth L.K., Diamandis E.P. Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer. J. Biol. Chem. 276:2001;53-61.
9. Yousef G.M., Chang A., Scorilas A., Diamandis E.P. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun. 276:2000;125-133.
10. Harvey T.J., Hooper J.D., Myers S.A., Stephenson S.A., Ashworth L.K., Clements J.A. Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J. Biol. Chem. 275:2000;37397-37406.
11. Mitsui S., Tsuruoka N., Yamashiro K., Nakazato H., Yamaguchi N. A novel form of human neuropsin, a brain-related serine protease, is generated by alternative splicing and is expressed preferentially in human adult brain. Eur. J. Biochem. 260:1999;627-634.
12. Yousef G.M., Diamandis E.P. The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics. 65:2000;184-194.
13. Angata T., Varki A. Cloning, characterization and phylogenetic analysis of Siglec-9, a new member of the CD33-related group of Siglecs. Evidence for co-evolution with sialic acid synthesis pathways. J. Biol. Chem. 275:2000;22127-22135.
14. Yousef G.M., Magklara A., Chang A., Jung K., Katsaros D., Diamandis E.P. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res. 61:2001;3425-3431.
15. Yousef G.M., Ordon M., Foussias G., Diamandis E.P. Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes. Gene. 286:2002;259-270.
16. Yousef G.M., Diamandis M., Jung K., Diamandis E.P. Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis. Genomics. 74:2001;385-395.
17. Yousef G.M., Diamandis E.P. The human tissue kallikreins: a new enzymatic cascade pathway? Biol. Chem. 383:2002;1045-1057.
18. Diamandis E.P., Yousef G.M., Clements J., Ashworth L.K., Yoshida S., Egelrud T.et al. New nomenclature for the human tissue kallikrein gene family. Clin. Chem. 46:2000;1855-1858.
19. Yamashiro K., Tsuruoka N., Kodama S., Tsujimoto M., Yamamura Y., Tanaka T.et al. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim. Biophys. Acta. 1350:1997;11-14.
20. Little S.P., Dixon E.P., Norris F., Buckley W., Becker G.W., Johnson M.et al. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J. Biol. Chem. 272:1997;25135-25142.
21. Scarisbrick I.A., Towner M.D., Isackson P.J. Nervous system-specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury. J. Neurosci. 17:1997;8156-8168.
22. Yousef G.M., Luo L.Y., Scherer S.W., Sotiropoulou G., Diamandis E.P. Molecular characterization of Zyme/Protease M/Neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease. Genomics. 62:1999;251-259.
23. Diamandis E.P., Yousef G.M., Soosaipillai A.R., Grass L., Porter A., Little S.et al. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clin. Biochem. 33:2000;369-375.
24. Okui A., Kominami K., Uemura H., Mitsui S., Yamaguchi N. Characterization of a brain-related serine protease, neurosin (human kaillikrein 6), in human cerebrospinal fluid. NeuroReport. 12:2001;1345-1350.
25. Scarisbrick I.A., Isackson P.J., Ciric B., Windebank A.J., Rodriguez M. MSP, a trypsin-like serine protease, is abundantly expressed in the human nervous system. J. Comp. Neurol. 431:2001;347-361.
26. Yoshida S., Taniguchi M., Hirata A., Shiosaka S. Sequence analysis and expression of human neuropsin cDNA and gene. Gene. 213:1998;9-16.
27. Yoshida S., Taniguchi M., Suemoto T., Oka T., He X., Shiosaka S. cDNA cloning and expression of a novel serine protease, TLSP. Biochim Biophys Acta. 1399:1998;225-228.
28. Yousef G.M., Scorilas A., Diamandis E.P. Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family. Genomics. 63:2000;88-96.
29. Mitsui S., Yamada T., Okui A., Kominami K., Uemura H., Yamaguchi N. A novel isoform of a kallikrein-like protease, TLSP/hippostasin, (PRSS20), is expressed in the human brain and prostate. Biochem. Biophys. Res. Commun. 272:2000;205-211.
30. Mitsui S., Okui A., Kominami K., Uemura H., Yamaguchi N. cDNA cloning and tissue-specific splicing variants of mouse hippostasin/TLSP (PRSS20). Biochim. Biophys. Acta. 1494:2000;206-210.
31. Liu X.L., Wazer D.E., Watanabe K., Band V. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 56:1996;3371-3379.
32. Luo L., Herbrick J.A., Scherer S.W., Beatty B., Squire J., Diamandis E.P. Structural characterization and mapping of the normal epithelial cell-specific 1 gene. Biochem. Biophys. Res. Commun. 247:1998;580-586.
33. Tanimoto H., Underwood L.J., Shigemasa K., Yan Yan M.S., Clarke J., Parmley T.H.et al. The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer. 86:1999;2074-2082.
34. Yousef G.M., Scorilas A., Magklara A., Soosaipillai A., Diamandis E.P. The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family-genomic characterization, mapping, tissue expression and hormonal regulation. Gene. 254:2000;119-128.
35. Yousef G.M., Magklara A., Diamandis E.P. KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer. Genomics. 69:2000;331-341.
36. Melegos D.N., Freedman M.S., Diamandis E.P. Prostate-specific antigen in cerebrospinal fluid. Clin. Chem. 43:1997;855.
37. Mannello F., Luchetti F., Falcieri E., Papa S., Gazzanelli G. Prostate-specific antigen expression in neuroblastoma cell lines. Clin. Chem. 44:1998;1362-1363.
38. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44:1992;1-80.
39. Schachter M. Kallikreins (kininogenases) - a group of serine proteases with bioregulatory actions. Pharmacol. Rev. 31:1979;1-17.
40. Mason A.J., Evans B.A., Cox D.R., Shine J., Richards R.I. Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides. Nature. 303:1983;300-307.
41. Rittenhouse H.G., Finlay J.A., Mikolajczyk S.D., Partin A.W. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci. 35:1998;275-368.
42. Frenette G., Tremblay R.R., Lazure C., Dube J.Y. Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator. Int. J. Cancer. 71:1997;897-899.
43. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest. 76:1985;1899-1903.
44. Cohen P., Graves H.C., Peehl D.M., Kamarei M., Giudice L.C., Rosenfeld R.G. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab. 75:1992;1046-1053.
45. Killian C.S., Corral D.A., Kawinski E., Constantine R.I. Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-beta and a proteolytic modulation of cell adhesion receptors. Biochem. Biophys. Res. Commun. 192:1993;940-947.
46. Heidtmann H.H., Nettelbeck D.M., Mingels A., Jager R., Welker H.G., Kontermann R.E. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen. Br. J. Cancer. 81:1999;1269-1273.
47. Sappino A.P., Madani R., Huarte J., Belin D., Kiss J.Z., Wohlwend A.et al. Extracellular proteolysis in the adult murine brain. J. Clin. Invest. 92:1993;679-685.
48. Seeds N.W., Siconolfi L.B., Haffke S.P. Neuronal extracellular proteases facilitate cell migration, axonal growth, and pathfinding. Cell Tissue Res. 290:1997;367-370.
49. Tsirka S.E., Gualandris A., Amaral D.G., Strickland S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature. 377:1995;340-344.
50. Suidan H.S., Stone S.R., Hemmings B.A., Monard D. Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron. 8:1992;363-375.
51. Gurwitz D., Cunningham D.D. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 85:1988;3440-3444.
52. Yamanaka H., He X., Matsumoto K., Shiosaka S., Yoshida S. Protease M/neurosin mRNA is expressed in mature oligodendrocytes. Brain Res. Mol. Brain Res. 71:1999;217-224.
53. Bernett M.J., Blaber S.I., Scarisbrick I.A., Dhanarajan P., Thompson S.M., Blaber M. Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277:2002;24562-24570.
54. Scarisbrick I.A., Blaber S.I., Lucchinetti C.F., Genain C.P., Blaber M., Rodriguez M. Activity of a newly identified serine protease in CNS demyelination. Brain. 125:2002;1283-1296.
55. Matsui H., Kimura A., Yamashiki N., Moriyama A., Kaya M., Yoshida I.et al. Molecular and biochemical characterization of a serine proteinase predominantly expressed in the medulla oblongata and cerebellar white matter of mouse brain. J. Biol. Chem. 275:2000;11050-11057.
56. Meier N., Dear T.N., Boehm T. A novel serine protease overexpressed in the hair follicles of nude mice. Biochem. Biophys. Res. Commun. 258:1999;374-378.
57. Petraki C.D., Karavana V.N., Skoufogiannis P.T., Little S.P., Howarth D.J., Yousef G.M.et al. The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry. J. Histochem. Cytochem. 49:2001;1431-1441.
58. Momota Y., Yoshida S., Ito J., Shibata M., Kato K., Sakurai K.et al. Blockade of neuropsin, a serine protease, ameliorates kindling epilepsy. Eur. J. Neurosci. 10:1998;760-764.
59. Chen Z.L., Yoshida S., Kato K., Momota Y., Suzuki J., Tanaka T.et al. Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J. Neurosci. 15:1995;5088-5097.
60. Okabe A., Momota Y., Yoshida S., Hirata A., Ito J., Nishino H.et al. Kindling induces neuropsin mRNA in the mouse brain. Brain Res. 728:1996;116-120.
61. Akita H., Matsuyama T., Iso H., Sugita M., Yoshida S. Effects of oxidative stress on the expression of limbic-specific protease neuropsin and avoidance learning in mice. Brain Res. 769:1997;86-96.
62. Suzuki J., Yoshida S., Chen Z.L., Momota Y., Kato K., Hirata A.et al. Ontogeny of neuropsin mRNA expression in the mouse brain. Neurosci. Res. 23:1995;345-351.
63. Komai S., Matsuyama T., Matsumoto K., Kato K., Kobayashi M., Imamura K.et al. Neuropsin regulates an early phase of schaffer-collateral long-term potentiation in the murine hippocampus. Eur. J. Neurosci. 12:2000;1479-1486.
64. Hirata A., Yoshida S., Inoue N., Matsumoto-Miyai K., Ninomiya A., Taniguchi M.et al. Abnormalities of synapses and neurons in the hippocampus of neuropsin-deficient mice. Mol. Cell. Neurosci. 17:2001;600-610.
65. Davies B.J., Pickard B.S., Steel M., Morris R.G., Lathe R. Serine proteases in rodent hippocampus. J. Biol. Chem. 273:1998;23004-23011.
66. Oka T., Akisada M., Okabe A., Sakurai K., Shiosaka S., Kato K. Extracellular serine protease neuropsin (KLK8) modulates neurite outgrowth and fasciculation of mouse hippocampal neurons in culture. Neurosci. Lett. 321:2002;141-144.
67. Selkoe D.J. Alzheimer's disease. In the beginning. Nature. 354:1991;432-433.
68. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:2002;353-356.
69. Ogawa K., Yamada T., Tsujioka Y., Taguchi J., Takahashi M., Tsuboi Y.et al. Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease. Psychiatry Clin. Neurosci. 54:2000;419-426.
70. Pericak-Vance M.A., Bebout J.L., Gaskell P.C. Jr., Yamaoka L.H., Hung W.Y., Alberts M.J.et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48:1991;1034-1050.
71. Yu C.E., Payami H., Olson J.M., Boehnke M., Wijsman E.M., Orr H.T.et al. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer's disease. Am. J. Hum. Genet. 54:1994;631-642.
72. Diamandis E.P., Yousef G.M., Petraki C., Soosaipillai A.R. Human kallikrein 6 as a biomarker of Alzheimer's disease. Clin. Biochem. 33:2000;663-667.
73. Zarghooni M., Soosaipillai A., Grass L., Scorilas A., Mirazimi N., Diamandis E.P. Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients. Clin. Biochem. 35:2002;225-231.
74. Shimizu-Okabe C., Yousef G.M., Diamandis E.P., Yoshida S., Shiosaka S., Fahnestock M. Expression of the kallikrein gene family in normal and Alzheimer's disease brain. NeuroReport. 12:2001;2747-2751.
75. Dihanich M., Spiess M. A novel serine proteinase-like sequence from human brain. Biochim. Biophys. Acta. 1218:1994;225-228.